OAC
CSBR icon

OMERS Administration Corp’s Champions Oncology CSBR Stock Holding History

OMERS Administration Corp’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,700
Closed -$92.9K – 917
2025
Q1 		$92.9K Buy
+10,700
New +$108K ﹤0.01% 976

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

OMERS Administration Corp's CSBR Position: Q2 2025 in Review

OMERS Administration Corp sold out of Champions Oncology (CSBR) in Q2 2025, closing a stake of 10,700 shares — an estimated $92.9K sold.

OMERS Administration Corp first reported a position in CSBR in Q1 2025 and held it in 1 quarter. The position peaked at $92.9K in Q1 2025. 30 funds tracked by Wall St. Rank hold CSBR as of Q2 2025.

  • OMERS Administration Corp reported no remaining Champions Oncology position as of Q2 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 10,700 Champions Oncology shares in Q2 2025, an estimated $92.9K.
  • OMERS Administration Corp first reported a position in Champions Oncology in Q1 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Champions Oncology position peaked at $92.9K in Q1 2025.
  • 30 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2025.

Based on OMERS Administration Corp's 13F filing for Q2 2025, filed 13 Aug 2025.